From: Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery
% | ||
---|---|---|
Age (years) | 58,6 | |
Male, n (%) | 22 | -73% |
Diabetes Mellitus, n | 11 | -36% |
Hypertension, n | 15 | -50% |
Smoking, n | 17 | -56% |
Ejection Fraction, n | 12 cases 35 > | -40% |
7 cases 36-50 | -23% | |
11 cases 51 < | -37% | |
Cardiopulmoner bypass time(Mean) | 81 min. | |
Cross clamp time(Mean) | 37 min. | |
Number of bypass vessel, n | CABG x1...1 | -3% |
CABG × 2...1 | -3% | |
CABG x3...11 | -33% | |
CABG x4...14 | -42% | |
CABG x5...3 | -9% | |
LIMA graft use, n | 27 | -90% |